A single-arm confirmatory trial of pazopanib in patients with paclitaxel-pretreated primary cutaneous angiosarcoma: Japan Clinical Oncology Group study (JCOG1605, JCOG-PCAS protocol)

BACKGROUND: Paclitaxel is a standard of care for patients with primary cutaneous angiosarcoma of the scalp and face. However, no standard second-line treatment for paclitaxel-resistant patients has ever been established. Since primary cutaneous angiosarcoma expresses a high level of vascular endothe...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:BMC Cancer
Asıl Yazarlar: Oashi, Kohei, Shibata, Taro, Namikawa, Kenjiro, Takahashi, Akira, Yokota, Kenji, Nakano, Eiji, Teramoto, Yukiko, Tsutsumida, Arata, Maeda, Taku, Yamazaki, Naoya
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: BioMed Central 2020
Konular:
Study Protocol
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC7359578/
https://ncbi.nlm.nih.gov/pubmed/32660439
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12885-020-07136-1
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller